These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. NK1 tachykinin receptor treatment is superior to capsaicin pre-treatment in improving functional outcome following acute ischemic stroke. Turner RJ, Vink R. Neuropeptides; 2014 Oct; 48(5):267-72. PubMed ID: 25151181 [Abstract] [Full Text] [Related]
5. Determining the Temporal Profile of Intracranial Pressure Changes Following Transient Stroke in an Ovine Model. Sorby-Adams AJ, Leonard AV, Elms LE, Marian OC, Hoving JW, Yassi N, Vink R, Thornton E, Turner RJ. Front Neurosci; 2019 Oct; 13():587. PubMed ID: 31338013 [Abstract] [Full Text] [Related]
6. A substance P antagonist improves outcome when administered 4 h after onset of ischaemic stroke. Turner RJ, Helps SC, Thornton E, Vink R. Brain Res; 2011 Jun 01; 1393():84-90. PubMed ID: 21466790 [Abstract] [Full Text] [Related]
7. Substance P antagonists as a novel intervention for brain edema and raised intracranial pressure. Gabrielian L, Helps SC, Thornton E, Turner RJ, Leonard AV, Vink R. Acta Neurochir Suppl; 2013 Jun 01; 118():201-4. PubMed ID: 23564132 [Abstract] [Full Text] [Related]
10. NK1 receptor blockade is ineffective in improving outcome following a balloon compression model of spinal cord injury. Leonard AV, Thornton E, Vink R. PLoS One; 2014 Jun 01; 9(5):e98364. PubMed ID: 24859234 [Abstract] [Full Text] [Related]
11. Investigating the therapeutic effects of nimodipine on vasogenic cerebral edema and blood-brain barrier impairment in an ischemic stroke rat model. Shadman J, Panahpour H, Alipour MR, Salimi A, Shahabi P, Azar SS. Neuropharmacology; 2024 Oct 01; 257():110054. PubMed ID: 38950691 [Abstract] [Full Text] [Related]
12. Human albumin aggravates cerebral edema by disrupting the blood‑brain barrier in a rat model of ischemic stroke. Li C, Zhang S, Jiang X, Li Z, Zhang Y, Li X, Ding H, Zeng H. Acta Neurobiol Exp (Wars); 2022 Oct 01; 82(3):284-294. PubMed ID: 36214711 [Abstract] [Full Text] [Related]
13. Intraventricular pre-treatment with rAAV-VEGF induces intracranial hypertension and aggravates ischemic injury at the early stage of transient focal cerebral ischemia in rats. Li Z, Wang R, Li S, Wei J, Zhang Z, Li G, Dou W, Wei Y, Feng M. Neurol Res; 2008 Oct 01; 30(8):868-75. PubMed ID: 18534058 [Abstract] [Full Text] [Related]
14. The protective effects of Axitinib on blood-brain barrier dysfunction and ischemia-reperfusion injury in acute ischemic stroke. Wang K, Zhou W, Wen L, Jin X, Meng T, Li S, Hong Y, Xu Y, Yuan H, Hu F. Exp Neurol; 2024 Sep 01; 379():114870. PubMed ID: 38897539 [Abstract] [Full Text] [Related]
15. Identification of an Intravenous Injectable NK1 Receptor Antagonist for Use in Traumatic Brain Injury. Vink R, Nimmo A. Int J Mol Sci; 2024 Mar 21; 25(6):. PubMed ID: 38542509 [Abstract] [Full Text] [Related]
16. Therapeutic time window for conivaptan treatment against stroke-evoked brain edema and blood-brain barrier disruption in mice. Zeynalov E, Jones SM, Elliott JP. PLoS One; 2017 Mar 21; 12(8):e0183985. PubMed ID: 28854286 [Abstract] [Full Text] [Related]
17. Inhibition of EphA4 reduces vasogenic edema after experimental stroke in mice by protecting the blood-brain barrier integrity. Zhang S, Zhao J, Sha WM, Zhang XP, Mai JY, Bartlett PF, Hou ST. J Cereb Blood Flow Metab; 2024 Mar 21; 44(3):419-433. PubMed ID: 37871622 [Abstract] [Full Text] [Related]
20. Methylene blue ameliorates brain edema in rats with experimental ischemic stroke via inhibiting aquaporin 4 expression. Shi ZF, Fang Q, Chen Y, Xu LX, Wu M, Jia M, Lu Y, Wang XX, Wang YJ, Yan X, Dong LP, Yuan F. Acta Pharmacol Sin; 2021 Mar 21; 42(3):382-392. PubMed ID: 32665706 [Abstract] [Full Text] [Related] Page: [Next] [New Search]